Chief Financial Officer
Haruhiko Shibuya joined Caris Diagnostics as Chief Financial Officer in November 2011. Prior to joining Caris Diagnostics, he served as the General Manager, Accounting & Finance Division of SRL Inc. In 2003, Shibuya joined Fujirebio Inc., as General Manager and served in this position until 2005. As a result of the 2005 merger between Fujirebio Inc., and SRL Inc., he was appointed General Manager, Accounting & Finance of Miraca Holdings Inc., and led the financial system establishment and subsidiary management after the merger until 2008 when he was transferred to SRL Inc. In 2010, when Fujirebio Inc., acquired Innogentics NV, an international diagnostic company in the fields of infectious diseases, genetic testing, transplantation, and neurodegeneration, he assumed the role as interim CFO. He has since returned to his current position when his successor joined Innogenetics NV in March 2011.
Before joining Miraca Holdings Inc., he worked for Nissho Iwai Corporation (Sojitz Corporation), one of the major Japanese general trading companies, as Finance Manager based in Tokyo, Japan and New York.